Pinsker Bret L, Moore Jeremy P, Bashore Thomas M, Krasuski Richard A
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Ahmanson/UCLA Adult Congenital Heart Disease Program, UCLA Health System, Los Angeles, California, USA.
JACC Adv. 2025 Apr;4(4):101667. doi: 10.1016/j.jacadv.2025.101667. Epub 2025 Mar 20.
Following the Fontan operation, electrophysiologic abnormalities requiring pacemaker implantation are common, consisting of sinus node dysfunction, complete atrioventricular block, and electromechanical dyssynchrony. Pacemaker implantation in this population can be challenging, as transvenous access to the cardiac chambers is often limited and may increase the risk of thromboembolism. Consequently, epicardial lead placement continues to be the default approach at most centers. Furthermore, permanent cardiac pacing has been associated with poor outcomes in this population (including an increased need for cardiac transplantation and death), even though it may be, depending on the approach, of great benefit for many individuals. Fortunately, improved understanding of the differential effects of cardiac pacing and novel approaches related to implantation have been developed and have increased their application to a growing number of patients. This review highlights the indications for pacing, methods to facilitate lead implantation, and associated outcomes in Fontan patients requiring permanent cardiac pacing.
在实施Fontan手术之后,需要植入起搏器的电生理异常情况很常见,包括窦房结功能障碍、完全性房室传导阻滞和机电不同步。在这一人群中植入起搏器可能具有挑战性,因为经静脉进入心腔往往受限,且可能增加血栓栓塞风险。因此,大多数中心仍将心外膜导线置入作为默认方法。此外,永久性心脏起搏与这一人群的不良预后相关(包括心脏移植需求增加和死亡),尽管根据植入方法的不同,它可能对许多人有很大益处。幸运的是,人们对心脏起搏的不同影响有了更好的理解,并开发了与植入相关的新方法,这使得它们在越来越多的患者中的应用有所增加。这篇综述重点介绍了Fontan患者需要永久性心脏起搏时的起搏指征、便于导线植入的方法以及相关预后。